# Matcha - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Custom As Needed Modality

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **84/100**
- **Evidence Quality Tier**: **bronze**
- **Human Clinical Evidence Strength**: 82/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 84/100 (Higher is safer)
- **Time Burden**: ~15 minutes/day
- **Estimated Monthly Cost**: moderate
- **Adherence Friction**: 3/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Operates via multi-target metabolic, mitochondrial, and cellular homeostatic pathways.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: Refer to individualized clinical assessment
- **Recommended Timing**: anytime
- **Administration Type**: Behavioral / Compound
- **Recommended Biomarkers to Monitor**: focus

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: None reported in standard human trials with recommended doses.
- **Safety Profile**: High Margin - Well tolerated within physiological ranges.

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Matcha Green Tea Improves Cognitive Function and Sustained Attention in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial** [PMID: 33919102]
   - Link: https://pubmed.ncbi.nlm.nih.gov/33919102/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Matcha on LongevityReviews](https://longevityreviews.org/modalities/matcha)
- **Last Evidence Calibration**: 2026-09-08
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.